Assessment of The Impact of Apremilast on Levels of IL-17, IL-23, and Lipids in Obese Psoriatic Patient
Background: Psoriasis is an immune-mediated inflammatory disease with unknown aetiology that may be associated with the defect in proliferation and differentiation of the keratinocytes related to inflammatory cell infiltration. According to published reports, it is universal in occurrence; its prev...
Saved in:
Main Authors: | Haitham M. Saad, Adil A. Noaimi, Halla Gh. Mahmood |
---|---|
Format: | Article |
Language: | English |
Published: |
College of Medicine University of Baghdad
2024-12-01
|
Series: | مجلة كلية الطب |
Subjects: | |
Online Access: | https://iqjmc.uobaghdad.edu.iq/index.php/19JFacMedBaghdad36/article/view/2260 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Safety of interleukin inhibitors in patients with plaque psoriasis and history of neoplasms: a multicenter retrospective study – IL PSO (Italian landscape psoriasis)
by: Mario Valenti, et al.
Published: (2025-12-01) -
Successful Treatment of Linear Psoriasis With the IL-17a-Antagonist Ixekizumab: A Case Report
by: Christov S, et al.
Published: (2025-01-01) -
Deciphering the role of IL17RA in psoriasis and chronic mucocutaneous candidiasis: shared pathways and distinct manifestations
by: Ayat Kadhi, et al.
Published: (2025-01-01) -
Effect of gut microbiota changes on cytokines IL-10 and IL-17 levels in liver transplantation patients
by: Mohamed Abdel-Raoof Fouda, et al.
Published: (2025-01-01) -
The frequency of distribution of the genotypes of the IL4 polymorphism (rs 2243250) in psoriasis and psoriatic arthritis
by: A. A. Barilo, et al.
Published: (2019-02-01)